Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: Four cases and a review of the literature

Fourteen cases of gynecomastia occurring during highly active antiretrovira l therapy (HAART) have been reported in the literature. To date, no specifi c therapeutic approach has been proposed, and gynecomastia has usually pers isted. We report 4 new cases of HAART-induced gynecomastia that were succes sfully treated with percutaneous dihydrotestosterone gel.